WHAT ARE THE CLINICAL AND ECONOMIC COSTS AND BENEFITS OF IMPLEMENTING POINT OF CARE TESTS FOR CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEA IN GENITO-URINARY MEDICINE CLINICS IN THE UNITED KINGDOM?